Argus
•
Apr 29, 2026
MEDP: Lowering target price to $455.00
Summary
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biote
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
Upgrade